Suk Kyoon An
Has grant
Research Interests
Make your next move.
Prepare your application
Review drafts before you send them.
Explore related searches
Recent Grants
Grant: Close
The basic science research program
Open Date:
Close Date:
Articles (13)
Year:
2026
Background Women with schizophrenia frequently discontinue antipsychotic medications during pregnancy. However, evidence on the risk of postpartum relapse associated with antipsychotic use during pregnancy is lacking. Aims To investigate the within-individual association between antipsychotic continuation during pregnancy and postpartum relapse in women with schizophrenia. Method This retrospective cohort study used data of women with schizophrenia who gave live birth between 2007 and 2018 identified from the National Health Information Database of South Korea. Women were classified according to antipsychotic use patterns during the 12 months before delivery as non-users, discontinuers and continuers. Relapse was defined as admission for psychosis (ICD-10, F20–29). The incidence rate ratio (IRR) for admission for psychosis in the 6-month postpartum period was estimated using conditional Poisson regression, with the reference period set between 2 and 1 years before delivery. Additionally, we calculated the relative risk ratios (RRRs) for the IRRs of different antipsychotic use patterns. Results Among the 3026 women included in the analysis (median age 34 years, interquartile range 31–37), the within-individual risk of admission for psychosis in the 6-month postpartum period was 0.56 times (RRR, 95% CI 0.36–0.87) lower in continuers (IRR = 1.31, 95% CI 0.89–1.72) than in discontinuers (IRR = 2.34, 95% CI 1.87–2.91). Among discontinuers, the IRRs of admission for psychosis in the 6-month postpartum period did not change significantly with the timing of discontinuation (trend P = 0.946). Conclusions Antipsychotic continuation during pregnancy was associated with a reduced risk of postpartum relapse in women with schizophrenia. Continuing antipsychotics during pregnancy would be recommended after a risk–benefit assessment.
Year:
2025
Background The At Risk Mental State (ARMS) (also known as the Ultra or Clinical High Risk) criteria identify individuals at high risk for psychotic disorder. However, there is a need to improve prediction as only about 18% of individuals meeting these criteria develop a psychosis with 12-months. We have developed and internally validated a prediction model using characteristics that could be used in routine practice. Methods We conducted a systematic review and individual participant data meta-analysis, followed by focus groups with clinicians and service users to ensure that identified factors were suitable for routine practice. The model was developed using logistic regression with backwards selection and an individual participant dataset. Model performance was evaluated via discrimination and calibration. Bootstrap resampling was used for internal validation. Results We received data from 26 studies contributing 3739 individuals; 2909 from 20 of these studies, of whom 359 developed psychosis, were available for model building. Age, functioning, disorders of thought content, perceptual abnormalities, disorganised speech, antipsychotic medication, cognitive behavioural therapy, depression and negative symptoms were associated with transition to psychosis. The final prediction model included disorders of thought content, disorganised speech and functioning. Discrimination of 0.68 (0.5-1 scale; 1=perfect discrimination) and calibration of 0.91 (0-1 scale; 1=perfect calibration) showed the model had fairly good predictive ability. Discussion The statistically robust prediction model, built using the largest dataset in the field to date, could be used to guide frequency of monitoring and enable rational use of health resources following assessment of external validity and clinical utility.
Year:
2025
Introduction Childhood trauma increases the risk of mental disorders by affecting both psychological and physiological stress responses in adulthood, including perceived stress and long-term hypothalamic-pituitary-adrenal (HPA) axis activity. The mechanisms underlying these effects may involve gene-environment (G × E) interactions, with the brain-derived neurotrophic factor (BDNF) gene Val66Met polymorphism and sex playing important roles. This study aims to investigate how childhood trauma influences stress responses, considering the BDNF Val66Met polymorphism and sex differences. Methods Secondary data from 190 healthy young adults (96 female) were analyzed. Childhood trauma and perceived stress were assessed using the Childhood Trauma Questionnaire (CTQ) and the Perceived Stress Scale (PSS), respectively, and hair cortisol concentration (HCC) was assessed as a measure of long-term cortisol levels. Participants were genotyped for the BDNF Val66Met polymorphism and stratified as Val/Val or Met carriers. Hierarchical linear regression models were used to examine the interactions between CTQ scores, BDNF Val66Met genotype, and sex to assess their effects on PSS scores and HCC. Additional analyses included separate linear regression models of the CTQ scores for HCC in Val/Val and Met carriers according to sex. Results Higher CTQ scores were positively associated with PSS scores in the entire sample (B= 0.124, p = 0.002). No significant main effects of CTQ scores, BDNF Val66Met genotype, or sex on HCC were observed. However, a significant three-way interaction between CTQ scores, BDNF Val66Met, and sex on HCC was observed, with a positive association between HCC and childhood trauma observed exclusively in female Val/Val carriers (B= 0.019, p=0.034). Conclusion These results demonstrated that childhood trauma elevates perceived stress across all participants and increases HCC levels, specifically in female Val/Val carriers.
Year:
2025
Year:
2025
Year:
2025
Hair cortisol concentration (HCC) reflects the long‐term activity of the hypothalamus‐pituitary‐adrenal (HPA) axis in response to stress. Brain‐derived neurotrophic factor DNA methylation (BDNF DNA M ) may affect HCC, and sex and Val66Met may contribute to this association. Thus, the aim of this study was to investigate the associations between HCC and Brain‐derived neurotrophic factor (BDNF) DNA M , and the moderating effects of Val66Met and sex. We recruited 191 healthy young participants (96 women, mean age 23.0 ± 2.6 years) and collected body samples to evaluate HCC, and to determine BDNF DNA M and Val66Met genotypes. We analyzed the effects of BDNF DNA M , sex, and Val66Met on HCC. We also evaluated the associations between BDNF DNA M and HCC in groups separated by sex and genotypes. We found a marked association of BDNF DNA M with HCC across men and women. After dividing the data by sex, a positive correlation of HCC with BDNF DNA M was found only in women. There was no substantial moderation effect of Val66Met genotypes on the association between BDNF DNA M and HCC. Therefore, BDNF DNA M was found to have positive association with HCC only in healthy young women, indicating that sex moderates the association of BDNF DNA M with long‐term HPA axis activity.
Year:
2024
Year:
2022
Year:
2021
Year:
2021
Year:
2021
Year:
2021
Year:
2020
Collaborators (12)
Erich Studerus
Lecturer / Researcher
University of Applied Sciences and Arts Northwestern Switzerland
Hye Yoon Park
Clinical Assistant Professor
Yonsei University College of Medicine
Pablo A Gaspar
Profesor Asociado
Universidad de Chile
Minji Bang
Assistant Professor
CHA Bundang Medical Center
Sun Jae Jung
Assistant Professor
Yonsei University College of Medicine
Eun Lee
Yonsei University College of Medicine
Catrin Tudur Smith
Personal Chair
University of Liverpool
Tim Ziermans
Academic, Assistant Professor
University of Amsterdam
Sophie Parker
Professor of Youth Mental Health
The University of Manchester
Anita Riecher-Rössler
University of Basel
Peter J. Uhlhaas
-
Laura Bonnett
Reader
University of Liverpool
Make your next move.
Prepare your application
Review drafts before you send them.